THE HALF-LIFE OF PASSIVELY ACQUIRED ANTIBODY GLOBULIN MOLECULES IN INFANTS by Wiener, Alexander S.
THE  HALF-LIFE  OF  PASSIVELY  ACQUIRED  ANTIBODY 
GLOBULIN MOLECULES  IN  INFANTS* 
Be ALEXANDER S.  WIENER, M.D. 
(From the Serological Laboratory of the Offw,  e of the Chief Medical Examiner  of the 
City of New York and the Blood Transfusion  Division of the 
Jewish Hospital of Brooklyn) 
(Received for publication, May 17, 1951) 
The purpose of this communication is to describe observations which make 
possible a reasonably accurate estimate of the haft-life of the antibody globulin 
molecule  in  man.  There  are  only a  few  studies  in  the  literature  which  are 
relevant  to  this  problem. 
Holman et al. (1)  showed that it is possible to maintain dogs on a protein-free  diet by 
administering  suitable  amounts of blood  plasma  intravenously.  These  workers  concluded 
that there is a  dynamic equilibrium  between plasma and tissue proteins  depending on the 
physiological needs. When proteins  are not available  in foods, the body can utilize amino 
acids from one body protein  to synthesize needed body protein  of a different kind. By trac- 
ing the fate of heavy nitrogen  (N  a)  incorporated  in the diet of rats,  Schoenheimer a  a/. 
(2) were able to show that body proteins in general, including plasma proteins, are in a state 
of dynamic equilibrium, with molecules constantly being broken down and regenerated from 
amino acids  derived  from the  diet.  In studies  on actively  immunized  rabbits which had 
passed the peak of their antibody titer,  Schoenheimer et al. (3, 4) found that heavy nitrogen 
fed in the diet was rapidly incorporated  into the antibody molecules. From the rate of elim- 
ination of the heavy nitrogen from the antibody, they concluded that in rabbits  the half-life 
of the antibody globulins in particular  and serum proteins  in general is about 14 days. 
Barr eta/. (5) studied the curve of elimination of passively acquired diphtheria  antitoxin 
in newborn infants  and concluded that the half-life of this antibody molecule in man is ap- 
proximately  4½ weeks. 
In the present  study on the haif-life of the antibody molecule in man,  we 
took advantage of a  situation which exists in certain cases of isosensitization 
in pregnancy. When a  sensitized  Rh-negative woman carries an Rh-negative 
fetus,  the Rh antibodies in her circulation pass through the placenta into the 
fetus until  an equilibrium  exists  between  the  two circulations,  so  that  when 
the baby is born its plasma contains Rh antibodies equal in titer to the "uni- 
valent" Rh antibodies in the maternalplasma (6). From the curve of elimination 
of the Rh antibodies  in  the newborn baby's plasma,  it should be possible  to 
estimate  the haft-life of the Rh antibody molecule in the baby's body. Since 
there is no reason to doubt  that  placenta-passing  antibodies  1 of other  speci- 
* Read before the American/~ssociation  of Immunologists  in Cleveland on May 1, 1951. 
1 For reasons pointed  out elsewhere (6), the present author believes that the antibodies 
capable of passing the intact placental  barrier, whether Rh antibodies or antibodies of other 
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ficities would behave in a  similar manner,  one  may infer  that  this  estimate 
would  apply to  all  such  antibodies,  and  presumably to  gamma globulin  in 
general. A limitation to following their disappearance is that the technique of 
serological titrations is relatively crude,  errors of one dilution  (100  per cent) 
being  not  uncommon.  However,  by  performing  the  titrations  blind,  and 
averaging the results of numerous titrations,  a  reasonable degree of accuracy 
is possible, and that was the procedure followed in  this study. 
RESULTS 
In Table I  are shown the results of two sets of observations on Rh-negative 
babies. In case 1 during the pregnancy the average of the numerous Rh anti- 
body titrations carried out on the mother's serum was 280 units, and the titer 
of the Rho antibodies found in the baby's serum at birth was 250 units, closely 
approximating the expected value. The antibody titer at any time following 
birth could be predicted with the aid of the following formula:  * 
W.Toe-k~ 
Zn  --  --  W~ 
where  To is the antibody titer at birth,  and  Wo the birth weight,  iv, is the 
antibody titer on the nth day, and W, the body weight on the nth day, and 
0.6932 
k=  Half-life in days. 
If one assumes that the half-life of the Rh antibody molecule in the baby 
is 30 days, it will be seen (Table I) that the expected titers calculated under 
this assumption agree closely with the actually observed titers. On the other 
hand, if we assume that the half-life of the antibody molecule is only 14 days 
as was reported by Schoenheimer et al.  for rabbits,  the calculated titers fail 
to agree well with  the present findings. 
The  same  method  of  analysis  was  applied  to  the  second  case  shown  in 
Table I. In this case the average antenatal Rh antibody titer was only 17 units 
and the antibody titer of the baby's serum at birth was 20 units.  This case 
was less favorable for study, because the lower initial titer made the period 
smaller  during  which  appreciable  amounts  of  antibodies  could  be  demon- 
strated  in  the  baby's serum.  Nevertheless  the  expected titers  calculated  on 
specificitie%  correspond  to  the  so-called  "univalent"  antibodies.  To  avoid  controversy, 
however, in this paper the noncommittal term "placenta-passing" antibody will be used. 
The observations and  conclusions presented here, therefore, do not apply  to  "bivalent" 
antibodies, which are incapable of passing the intact placental barrier. 
2 This formula is similar to that used to determine the half-life of radioactive elements; 
Wo  the factor ~  is necessary to allow  for the dilution resulting from the baby's increasing body 
weight and volume of body fluids. The formula is also similar to that for the percentage 
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the  assumption  of a  half-life of  30  days again  agree  satisfactorily with  the 
observed values. To be sure,  the titers obtained on the  78th  and  110th  days 
were  lower than the expected values, but  the difference was  only one  serum 
dilution and  therefore not  significant. 
TABLE I 
Titer of Passively Acquired Rh Antibody in Rdation to the Baby's Age in Two Normal 
Rh-Negative Babies 
Case 
No.  Date of test 
During pregnancy 
(average) 
3/31/49 
6/22/49 
9/13/49 
5/5/50 
During pregnancy 
(average) 
8/6/47 
8/25/47 
9/22/47 
10/23/47 
11/24/47 
Titer* 
of Rh 
I  an  tilb2y ]  'S 
ImsaetrernumM  I  beY 
days 
280  -- 
280 
280 
180 
100 
17 
22 
12 
12 
14 
11 
0 
93 
176 
450 
0 
19 
47 
78 
110 
Weight 
5lb.,  5oz. 
10 lb., 11 oz. 
15 lb.,  6 oz. 
4 lb., 14 oz. 
5 lb., 13 oz. 
8 lb.,  7 oz. 
10 lb., 14 oz. 
12 lb., 15 oz. 
Wo 
1.0 
0.50 
0.35 
0.225 
1.0 
O. 83 
0.58 
0.44 
0.38 
Titer of Rh antibody 
in baby's serum 
Calculated: based 
Oh-  I  on half-life of 
served  --  -- 
30 days  15 days 
50  280  280 
20  17.0  1.9 
2  1.7  0.028 
0!  0.0018  -- 
20  17  17 
11  9.2  5.9 
5  3.3  1.1 
0  15  1.2  0.20 
0  25  0.5  0.04 
For details concerning  the albumin-plasma conglutination method cf. Wiener and Hurst 
(18). 
* All titers represent the average of several tests by the albumin-plasma conglutination 
method. 
:~ Based on figures kindly provided by Dr. I. B. Wexler for monthly gain in weight of 
normal infants treated by him. 
§ Also negative in tests with enzyme-treated cells. 
It is reasonable to assume that the 30 day estimate for half-life applies not 
only to Rh antibodies but to placenta-passing antibodies in general. A  search 
was therefore made in the literature for comparable data on other antibodies 
to which the formula could be applied, and in Table II the data of Neill et aL 
(8)  on diphtheria antitoxic antibodies have been analyzed. In this case, tests 
were not performed on the mother and baby at the time of birth,  so that it 
is uncertain whether the expected antibody titer of the baby's serum at birth 
should be 2.75 units (the titer of the maternal serum 138 days before delivery) 
or 3.50 units (the titer of the maternal serum 20 days after delivery). However, 216  HALF-LIFE Ol  ~ ANTIBODY GLOBULIN MOLECULES 
in either case the fit between the calculated and observed values is sufficiently 
close, indicating that the half-life of antitoxic antibodies is also approximately 
30 days. 
Recently we have been studying the fate of the Rh antibody molecule in 
Rh-positive babies.  When  the  baby  of  a  sensitized  Rh-negative woman is 
Rh positive, the Rh antibodies passively transferred through the placenta are 
adsorbed by the fetal red cells,  so that the titer of free Rh antibodies in the 
baby's serum is, as a rule, considerably lower than the maternal antibody titer. 
By using enzyme-treated Rh-positive red ceils for titrating the free antibodies, 
however, significant titers can usually be obtained. In Table III are shown 3 
TABLE II 
Titer  of Passivdy  Acquired Diphtheria Antitoxic Antibodies in  Rdation  to the Baby's  Age 
(Data,  r NeiU et al. (8)) 
Age of baby 
days 
-- 138 
0 
2O 
81 
168 
28O 
Titer of 
antitoxic antibodies in 
maternal serum 
un~s 
2.75 
3.50 
3.75 
3.50 
2.25 
Wo 
w~ 
(probable*) 
1.0 
0.88 
0.58 
0.42 
0.34 
Titer of antitoxic antibodies 
in baby's  serum 
Observed 
un~s 
1.75 
0.50 
0.10 
0.002 
Calculated; based on 
half-life  of 30 days 
(a)t  (b)t 
units  ~s 
2.75  3.50 
1.50  1.91 
0.25  0.31 
0.028  0.035 
0.0015  0.0018 
* Based on figures kindly provided by Dr. I. B. Wexler for monthly gain in weight of nor- 
mal infants treated by him. 
Based on maternal titer (a) at -138 days; (b) at -I-20 days. 
representative cases in which the fate of the free Rh antibodies in R_h-positive 
babies was determined. In all three cases the R_h antibodies disappeared at 
approximately the same rate as in the two Rh negative babies shown in Table 
I, that is to say they had a half-life of approximately 30 days. This may seem 
surprising until one considers that the baby's red cells have already adsorbed 
as much antibody as possible, so that until the baby's body produces fresh 
Rh antigen to neutralize the free Rh antibodies, the latter will disappear at 
the  same  rate as  in Rh-negative babies.  Therefore,  only in babies in which 
fresh Rh-positive red cells are being produced would the free Rh antibodies 
have a half-life of less than 30 days, as in the case recently reported by Griffitts 
and Nock (9), and other cases recently seen by us. 
DISCUSSION 
The situation in the case of the alpha and beta isoantibodies is quite differ- 
ent from cases of Rh sensitization. Where the baby belongs to an incompatible ALEXANDER  S.  WIENER  217 
TABLE III 
Titer of Passively Acquired Rh Antibodies in  Relation to Baby's Age in  Rh-Positive Babies 
Ca~e 
No, 
1§ 
2§ 
Ageofb~y 
days 
Antenatal 
At birth 
14 
33 
70 
Antenatal 
At birth 
10 
21 
28 
33 
43 
63 
75 
119 
Maternal Rh 
antibody fiter" 
wu/ts 
38 
88 
400 
230 
Aati-Rl~ i Anfi-rh' 
b 
units  units 
Wo 
w, 
(probable) 
D 
1.0 
0.92 
0.81 
0.63 
1.0 
0.95 
0.89 
0.84 
0.81 
0.75 
0.64 
0.60 
0.51 
"liter* of Rh antibodies in baby's 
seriLnl 
Observed 
units 
4.5 
3 
2 
0.75 
13 
17.5 
5.5 
17 
3 
3 
3.5 
2.5 
1.25 
Anti-Rho Anti-rh' 
units  units 
Expected~ 
units 
i 
4.511 
2.9 
!  1.6 
0.57 
23.3 
17.511 
12.5 
10.1 
8.6 
6.2 
3.4 
3.0 
0.7 
Anti-Rho  Antl-rh' 
units  units 
3§  5 
43 
65 
74 
102 
136 
164 
960 
1920 
1400 
7~ 
i  1600 
I  3460 
1600  I 
i  320  I 
1.0 
0.75 
0.64 
0.61 
0.53 
0.47 
0.45 
320 
350 
128 
32 
14 
3 
3 
96  32011  9611 
22  98.4  29.5 
48  49.1  14.7 
14  39.0  11.7 
7  17.0  5.1 
3  7.4  2.1 
3  3.6  1.0 
* Titer values represent average of at least two titrations against enzyme-treated (ficinated) 
red  cells. 
;~ On the assumption of a half-llfe of 30 days. 
§ In case i, the baby had subclinical erythroblastosis and recovered without treatment; 
in case 2, the baby recovered after an exchange transfusion with 150 cc. packed cells followed 
several days later by a  supplementary transfusion of 60 cc. of packed red cells; in case 3, 
the baby recovered after treatment with a number of transfusions of packed red cells over a 
period of 3 months. 
11 In this column, the values indicated were arbitrarily set equal to the observed values. 
blood  group,  the  incompatible  isoantibodies  passively  acquired  by  the  baby 
from its mother are usually completely neutralized, and only when the maternal 
antibody  titer  is exceptionally high  are appreciable  quantities  of free incom- 
patible  isoantibodies  demonstrable  in  the  baby's  serum.  Such  free  incom- 
patible  isoantibodies  are rapidly  eliminated,  as a  rule,  and  no  longer demon- 2i8  HAL]?-LIFE  OF  ANTIBODY  GLOBULIN  MOLECULES 
strable after  a  week or 2  (10).  The difference in behavior of alpha  and beta 
isoantibodies  and  Rh  antibodies  is  understandable  when  one  considers  that 
the A and B group substances are present in most organ and tissue cells, while 
the Rh antigens appear to be restricted to the red cells. Moreover, in secretors, 
freshly formed A and B substances in solution would tend to neutralize quickly 
any  free  incompatible  isoantibodies. 
It would appear  that  these  findings  provide an explanation  for the  lower 
incidence of erythroblastosis caused by sensitization to the A  or B agglutinogen 
compared  with  cases  of  Rh  sensitization.  They  furnish  further  indirect 
evidence supporting the previous observations of Wiener (11) and Levine (12) 
that  the  Rh  antigen  does  not  occur  in  significant  amounts  in  secretions  or 
body fluids. The observations also explain why transfusions of maternal whole 
blood  are  generally  successful  for  treating  erythroblastotic  babies  (13);  the 
additional  introduced  maternal  Rh  antibodies  could  scarcely  aggravate  the 
situation because the baby's red cells have already adsorbed as much of them 
as possible,  and  the  slight  rise  in titer  of free  Rh  antibodies  resulting  from 
the introduction of maternal plasma would be relatively unimportant. 
In the study of Barr eta/.  (5) it was found that the titer of diphtheria  anti- 
toxin in umbilical cord serum was consistently higher than the titer of the anti- 
toxin in the mother's serum. In a previous study (7) the present writer found 
that the titer  of Rh antibodies  in R_h-negative babies is always equal to the 
titer  of  the  placenta-passing  Rh  antibodies  in  the  serum  of their  sensitized 
mothers, indicating that the baby's Rh antibodies had been passively acquired 
from their mothers by placental  transfer in utero.  If all antibodies present  in 
the newborn are passively acquired from the mother,  then their  titers  would 
not be expected  to exceed  the  maternal  antibody  titers. 
Barr et a~. remark  that any satisfactory  theory concerning neonatal  immunity must ac- 
count for the unexpected findings obtained by them in their studies on diphtheria  antitoxin. 
The present writer believes that the high antitoxin  titers obtained  by Barr et aJ. with um- 
bilical cord sera were due to the presence in such sera of some contaminant,  perhaps Whar- 
ton's jelly, which interferes with the skin tests. Significantly, in 5 babies in whom the antitoxin 
titrations  were repeated  2 to 5 days after birth,  the titers obtained at the second test more 
closely approximated the maternal values, the average ratio of the baby's titer to the maternal 
titer being 0.88 instead of the ratio 1.67 obtained with umbilical cord serum. Barr et al. made 
a graph of the diphtheria  antitoxin  titers  expressed as percentage  of the titer of the cord 
serum in babies up to the age of 40 weeks, and found that the logarithms of the titers fell 
approximately  on a straight  line. From the line fitted  to the plotted  titers  they derived an 
empirical formula from which they estimated  the half-life of the antitoxin  molecule to be 
4½ weeks, which agrees closely with the value of 30 days now obtained  for Rh antibodies. 
In Table IV the data of Barr et ~zl. have been analyzed with the aid of the formula used in 
the present paper,  and the results obtained  confirm their  estimate  of the half-life as 30 to 
35 days. In the graph of Barr et aJ. the logarithms of all the titers fell on a straight line ex- 
cept the value for umbilical cord sera. If this  straight line is extended backwards until it 
intersects the ordinate, the value obtained in this way for the newborn child is approximately ALEXANDER  S.  WIENER  219 
equal to the maternal antibody titer, as expected. This further supports the present writer's 
suggestion that the higher titers obtained by Barr e~ al. with umbilical cord serum were due 
to some contaminant which interfered with the tests. 
It is of interest to determine the half-life for antibody molecules in various 
animal  species by using  the method  described  in  this paper.  There  are  some 
published  data  to  which  the  formula  can  be applied. 
TABLE IV 
Titer of Passively Acquired  Diphtheria Antibodies  in Relation to Baby's  Age  (Data of Barr 
a  al. (5)) 
Age of baby 
days 
47 
59 
73 
88 
118 
131 
149 
215 
253 
Wo 
w. 
(probable*) 
0.73 
0.65 
0.62 
0.57 
0.50 
0.48 
0.45 
0.39 
0.37 
Titer of antitoxlc antibodies expressed as percentage of titer of 
umbilical cord serum 
Observed 
:orrected  Corrected~ 
J 
',5.1  42.2 
6.2  27.2 
5.3  25.7 
1.4  19.1 
3.78  6.3 
4.23  7.1 
2.13  3.6 
0.74  1.2 
0.31  0.5 
Expected, based on half-life of 
30d~s  35d~s 
Un- 
corrected§ 
37.7 
25.6 
18.6 
13.l 
6.5 
4.8 
3.2 
0.7 
0.3 
Corrcctcdll 
24.5 
16.6 
11.5 
7.4 
3.3 
2.3 
1.4 
0.3 
0.1 
Un-  : Correctedl[  corrected§ 
39.7  28.9 
31.3  20.3 
23.7  14.7 
17.7  10.1 
9.8  4.9 
7.6  3.6 
5.3  2.4 
1.4  0.6 
0.7  0.3 
* See foot note to Table II. 
:~ Multiplied by factor 1.68 to correct for high titer readings given by umbilical cord sera. 
§ Values obtained by using formula Tn  =  Toe  -'~. 
[] Corrected for weight gain by multiplying by factor in second column. 
Richardson  (14)  for example found in guinea pigs immunized antenatally against  diph- 
theria bacilli that  the titer of the antibacterial  antibodies in the offspring  at  1 month of 
age is usually about one-eighth the titer of the maternal serum.  When one  considers that 
guinea pigs quadruple their birth weight by the time they reach 1 month of age, these results 
agree  satisfactorily with  the  assumption  that  the  half-life of placenta-passing  antibodies 
in guinea pigs is also 30 days. The study of Mason et al. (15) on the transmission of maternal 
immunity for lamb dysentery is also of interest in this connection. According to the data 
in the tables of their paper,  the antibody titers in Iambs at 30 days are approximately one- 
fifth to one-sixth the titer immediately after ingestion of colostrum at birth. When one con- 
siders that lambs triple their birth weight by the time they reach 1 month of age, this also 
fits satisfactorily with the assumption of a half-life of 30 days. As has already been mentioned, 
by a different method Schoenheimer eta/. (3) estimated the half-life of antibodies in rabbits 
to be only 14 days. Unfortunately, there are no published data from which one can calculate 
the half-life for this species,  using the method described in this paper. 220  HAL~-LI~E  OF  ANTIBODY  GLOBULIN  MOLECULES 
Since the constitution of placenta-passing antibodies appears to have much 
in common with that of serum gamma globulin,  it seems reasonable to conclude 
that  the estimated half-life  of 30 days for placenta-passing  antibodies prob- 
ably applies to serum gamma globulin in general.  The  question then  arises 
whether all serum gamma globulins present in the newborn infant  are pas- 
sively acquired from the mother by placental transfer,  like placenta-passing 
antibodies. Wiener, Berger, and Lenke (16) have therefore carried out electro- 
phoretic studies on sera from babies during the first 6 months of life. In con- 
formity with the observations of Moore et al.  (17) they found that the serum 
gamma globulin peak at birth is about equal to that of the maternal serum, 
and that the peak diminishes and is at its lowest point by the time the baby 
is 3 months old.  On the basis of these findings  it is reasonable to conclude 
that  a  considerable portion  and  perhaps  all  of the  gamma  globulin  in  the 
newborn child is derived from the mother, and that it is relatively incapable 
of producing gamma globulin in general and antibodies in particular. However, 
the gamma globulin peak diminishes  more slowly than would be expected by 
assuming  a  half-life  of 30 days, a  fact suggesting  that  the gamma globulin 
is slowly undergoing replacement by synthesis in the newborn. The relative 
inability of the latter to produce antibodies, a fact attested by a large litera- 
ture, will  explain  the occurrence of certain instances of overwhelming  sepsis 
without any constitutional reaction until sudden death takes place. 
SUMMARY 
By following  the titer of passively acquired Rh antibodies in newborn in- 
fants, it is calculated that  the half-life  of the placenta-passing  Rh antibody 
molecule is  approximately  30  days.  Evidence  is  offered that  this  estimate 
applies not only to placenta-passing Rh antibodies, but also to other placenta- 
passing antibodies, and not improbably to serum gamma globulin  molecules 
in general. 
Studies on the fate of free Rh antibodies in erythroblastotic babies show that 
these antibodies often are eliminated  no more rapidly in Rh-positive babies 
than in Rh-negative babies. On the other hand, incompatible alpha and beta 
antibodies, as a rule,  are quickly neutralized and eliminated from the body of 
newborn infants.  These  observations provide one explanation  for the lower 
incidence  of erythroblastosis due to A-B sensitization in comparison with cases 
resulting from Rh sensitization. 
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